|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Dendreon Names John Johnson CEO After Volatile Year
|
Arlene Weintraub |
02/01/12 |
Seattle
|
|
Monster Slashes 400 Jobs, Restructures for Profitability
|
Gregory T. Huang |
01/26/12 |
Boston
|
|
Clearwire Shares Go for Another Ride on Word of Latest Sprint Plans
|
Curt Woodward |
10/26/11 |
Seattle
|
|
PayPal’s Pickup of Fig Card, the End of Eons, and the Bose-MIT Lovefest—Some Thoughts
|
Gregory T. Huang |
05/02/11 |
Boston
|
|
Semyon Dukach, the MIT Blackjack King, Takes SMTP Public in Latest Effort to Fight the Power
|
Gregory T. Huang |
05/02/11 |
Boston
|
|
Vertex Stock Up 15 Percent on CF Data
|
Ryan McBride |
02/23/11 |
Boston
|
|
Progress Software CEO Richard Reidy Talks “Major Transition” and “Whole New Strategy”
|
Gregory T. Huang |
12/21/10 |
Boston
|
|
Report: SEC Probing 3Com for Potential Insider Trading
|
Wade Roush |
11/16/09 |
Boston
|
|
Akamai And Delve Dig Into Online Video, Cardiorobotics Snags $11.6M for Snake-Like Surgery Robot, Longworth Collects $122M, & More Boston-Area Deals News
|
Rebecca Zacks |
08/07/09 |
Boston
|
|
World Energy Joins NASDAQ
|
Wade Roush |
04/27/09 |
Boston
|
|
Loud to Delist Stock from NASDAQ
|
Gregory T. Huang |
01/16/09 |
Seattle
|
|
Brightcove Bonds With AOL, Faces Competition With Akamai; Fidelity Backs EnVivo; Dyax to Sell Up To $50M in Stock; & More Boston-Area Deals News
|
Rebecca Zacks |
11/03/08 |
Boston
|
|
Biogen Idec Makes Controversial Tysabri Decision, Boston Scientific Explains Stock Sales, Charles River Heads to China, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
10/16/08 |
Boston
|
|
BSX CEO Buys 350K Shares
|
Rebecca Zacks |
10/10/08 |
Boston
|
|
What Does the Financial Crisis Mean for Innovation? Xconomists Weigh In
|
Robert Buderi |
09/30/08 |
National
|
|
Clinical Data Inks $25M Stock Deal
|
Rebecca Zacks |
09/29/08 |
Boston
|
|
Vertex Offering Up To $220M
|
Rebecca Zacks |
09/22/08 |
Boston
|
|
Cell Therapeutics Authorizes 1-for-10 Reverse Stock Split
|
Luke Timmerman |
08/25/08 |
Seattle
|
|
GT Solar Pulls Off IPO, Esther Dyson and Tim O’Reilly Back Good Data, BioEnergy Bonds with OmniGene, & More Deals News
|
Rebecca Zacks |
07/28/08 |
Boston
|
|
GT Solar Set to Break IPO Drought
|
Wade Roush |
07/22/08 |
Boston
|
|
$37 Million for Nanotech Insulation, $25 Million for ImmunoGen, $325 Million for Evergreen Solar, & More Deals News
|
Rebecca Zacks |
06/30/08 |
Boston
|
|
Evergreen Solar Plans $300M Note Sale
|
Rebecca Zacks |
06/25/08 |
Boston
|
|
Health 2.0 Firms in the Spotlight, Biogen Board in the Clear, Alnylam in Asia, & More Life Sciences News
|
Rebecca Zacks |
06/25/08 |
Boston
|
|
RXi Plans $8.7M Stock Sale
|
Rebecca Zacks |
06/24/08 |
Boston
|
|
Icahn Nominee Concedes Defeat at Biogen Idec Annual Meeting
|
Robert Buderi |
06/19/08 |
Boston
|
|
Icahn Jabs Biogen Idec, Says Its Board Had `Very Little’ Input in Sale Process
|
Luke Timmerman |
06/05/08 |
Boston
|
|
Indevus Drug Delayed by FDA Safety Questions, Shares Plummet
|
Luke Timmerman |
06/04/08 |
Boston
|
|
Evergreen Rakes in the Green, NxStage Plans Two-Stage Deal, Atlas Places Big Bet on MicroRNA, & More Deals News
|
Rebecca Zacks |
05/27/08 |
Boston
|
|
Shares of Evergreen Solar Shine After $1 Billion Contract News
|
Rebecca Zacks |
05/22/08 |
Boston
|
|
Geezeo Takes a Walk on The Sunny Side of TheStreet.com
|
Wade Roush |
04/24/08 |
Boston
|
|
Page 1 of
2 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.